Atlas FDA

Avalus Ultra Bioprosthesis

FDA premarket approval P170006/S025 · decided 2024-01-31

Approval details

PMA number
P170006
Supplement
S025
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Avalus Ultra Bioprosthesis
Generic name
heart-valve, non-allograft tissue
Applicant
Medtronic, Inc.
Date received
2023-09-01
Decision date
2024-01-31
Days to decision
152 days
Decision code
APPR
Product code
LWR
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Ana, CA
Statement
Approval for design modifications to the Avalus Bioprosthesis device including the addition of a radiopaque marker and changes to the stent base design and sewing ring. The device, as modified, will be marketed under the trade name Avalus Ultra Bioprosthesis.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19